The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

The addition of epcoritamab to standard therapy significantly improved PFS for patients with relapsed or refractory follicular lymphoma, according to study results presented at ASH Annual Meeting and ...

First-line treatment selection in follicular lymphoma is closely tied to tumor stage, disease burden, and patient-specific ...

Follicular lymphoma is often underrecognized not only for its clinical complexity but also for the significant financial ...

Genentech, a subsidiary of the Roche Group, has received the US Food and Drug Administration’s (FDA) accelerated approval for ...

To diagnose non-Hodgkin‘s lymphoma, doctors may use blood tests, biopsies, and imaging scans such as CT scans or MRIs. These tests help doctors confirm the presence of the disease and plan the right ...

While both women and men may experience classic symptoms of lymphoma, women may have different symptoms if the lymphoma has developed in a reproductive organs. Lymphoma is a type of cancer that ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the best stocks to buy for the next 5 years. On December 15, Goldman Sachs ...

Fred Hutch researchers pioneered bone marrow transplantation, one of the most significant advances in treating lymphoma, leukemia and other blood cancers. We continue to improve bone marrow and blood ...

People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly ...